Professor Piepoli obtained his Diploma in Medicine in Università di Pavia in 1987 where he specialized in Cardiology in 1991. In 1996 he obtained his Degree Doctor of Philosophy in the field of Medicine, (Cardiology), Imperial College, London, UK.
He currently heads the Heart Failure and Cardiomiopathy Unit of the Guglielmo da Saliceto Hospital in Piacenza. He is Teaching Professor in School of Cardiology of the University of Parma and at the Fondazione Monasterio, and Scuolas Superiore Sant'Anna in Pisa. He is the Chair of the 6th Joint Task Force responsible for the 2016 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice.
In 2000 the Italian Society of Cardiology awarded him the title of “Scholar”.
From 2012 till 2018 we hold the position of CPG member of the ESC.
He is Board member of the HFA.
Since 2017 he is Editor-in-Chief of European Journal of Preventive Cardiology (IF 5.64) and ex-officio member of the EAPC
Latest evidence in heart failure management: what is emerging between 2016 and 2021 Guidelines?
Speaker : M
Joint session with the Heart Failure Association (HFA) - This session is supported by Boehringer Ingelheim and Lilly Alliance in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease